| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/10/2002 | WO2002016377A3 Human cytidine monophosphate (cmp) kinase cdna |
| 05/10/2002 | WO2002015927A8 High mannose proteins and methods of making high mannose proteins |
| 05/10/2002 | WO2002014468A3 Phage-dependent superproduction of biologically active protein and peptides |
| 05/10/2002 | WO2002009641A3 Promyostatin peptides and methods of using same |
| 05/10/2002 | WO2002008461A3 A METHOD AND AN ALGORITHM FOR mRNA EXPRESSION ANALYSIS |
| 05/10/2002 | WO2002006447A3 Salicylic acid biosynthetic genes and uses thereof |
| 05/10/2002 | WO2002004644A3 Aspartylprotease |
| 05/10/2002 | WO2002003812A3 Animal feed containing polypeptides |
| 05/10/2002 | WO2002002753A3 Nucleotide sequence encoding benzaldehyde lyase and method for the stereoselective synthesis of 2-hydroxy ketones |
| 05/10/2002 | WO2002002608A3 NEW SODIUM CHANNEL (rNaV1.5a) AND USE THEREOF |
| 05/10/2002 | WO2002000885A9 Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 05/10/2002 | WO2002000824A3 A NOVEL POLYPEPTIDE, A HUMAN tre ONCOGENE 10.56 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE |
| 05/10/2002 | WO2002000823A3 A novel polypeptide, a enzymatic activation protein ras gtp 9.57 and the polynucleotide encoding the polypeptide |
| 05/10/2002 | WO2002000821A3 A novel polypeptide, a human protein plp39 and the polynucleotide encoding the polypeptide |
| 05/10/2002 | WO2001098514A3 Targeting viral vectors to specific cells |
| 05/10/2002 | WO2001098338A3 Fluorescent proteins |
| 05/10/2002 | WO2001096578A3 Protein production in aureobasidium pullulans |
| 05/10/2002 | WO2001096526A3 A novel polypeptide, a human tumor suppressor factor 11.77 and the polynucleotide encoding the polypeptide |
| 05/10/2002 | WO2001096392A3 22109, a novel human thioredoxin family member and uses thereof |
| 05/10/2002 | WO2001094950A3 Screening of phage displayed peptides without clearing of the cell culture |
| 05/10/2002 | WO2001094385A3 Human hm74-like g protein coupled receptor |
| 05/10/2002 | WO2001093669A3 Compound screens relating to insulin deficiency or insulin resistance |
| 05/10/2002 | WO2001092489A3 Palmitate desaturase gene |
| 05/10/2002 | WO2001092337A3 Soluble ctla4 mutant molecules and uses thereof |
| 05/10/2002 | WO2001090304A3 Nucleic acids, proteins, and antibodies |
| 05/10/2002 | WO2001088116A3 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods |
| 05/10/2002 | WO2001087931A3 Bacterial insecticidal proteins |
| 05/10/2002 | WO2001085993A3 Method for detecting growth hormone variations in humans, the variations and their uses |
| 05/10/2002 | WO2001083771A3 Human phospholipase c delta 5 |
| 05/10/2002 | WO2001083750A3 Dendritic cell co-stimulator molecules |
| 05/10/2002 | WO2001083711A3 Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus |
| 05/10/2002 | WO2001081566A3 Apparatus and method for separating and purifying polynucleotides |
| 05/10/2002 | WO2001079539A3 Method for using transfectable constructions from luciferase and from the promotor of the human period 1 gene for identifying novel active substances that influence the day/night rhythm and sleep |
| 05/10/2002 | WO2001079516A3 Maize cellulose synthases and uses thereof |
| 05/10/2002 | WO2001079469A3 Cloning of corynebacteriaceae histidine ammonia lyase and therapeutic uses |
| 05/10/2002 | WO2001075141A3 Biosensor chip |
| 05/10/2002 | WO2001075116A3 ISOLATED NUCLEIC ACIDS FROM MICROMONOSPORA ROSARIA PLASMID pMR2 AND VECTORS MADE THEREFROM |
| 05/10/2002 | WO2001072959A3 Plastid transformation vectors for expressing human proteins in plants |
| 05/10/2002 | WO2001070808A3 Angiogenesis - associated proteins, and nucleic acids encoding the same |
| 05/10/2002 | WO2001068697A3 Methods and compositions for immunoregulation |
| 05/10/2002 | WO2001068677A3 Derivatives of breast canacer antigen her-2 for therapeutical use |
| 05/10/2002 | WO2001066778A3 Production of foreign polypeptides in plants as viral coat protein fusions |
| 05/10/2002 | WO2001066742A3 G-protein coupled receptors |
| 05/10/2002 | WO2001066715A3 Rapid generation of recombinant adenoviral vectors |
| 05/10/2002 | WO2001066594A3 Human protein kinases and protein kinase-like enzymes |
| 05/10/2002 | WO2001066573A3 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 05/10/2002 | WO2001064912A3 Triazine degrading enzymes |
| 05/10/2002 | WO2001064908A3 14790, a protein kinase and uses therefor |
| 05/10/2002 | WO2001064897A3 Mutant bacterial strains of the genus sphingonomas deficient in production of polyhydroxybutyrate and process of clarification of sphingans |
| 05/10/2002 | WO2001064891A3 Nucleotide sequences for embryo and/or endosperm specific expression in plants |
| 05/10/2002 | WO2001064879A3 G-proteins coupled receptor related polypeptides |
| 05/10/2002 | WO2001064031A3 Slpi knockout mice and methods for wound treatment |
| 05/10/2002 | WO2001062779A3 New transcription factor carp-2 |
| 05/10/2002 | WO2001057234A3 Biopolymer thickener |
| 05/10/2002 | WO2001055323A3 Nucleic acids, proteins, and antibodies |
| 05/10/2002 | WO2001051620A3 Pullulanase variants and methods for preparing such variants with predetermined properties |
| 05/10/2002 | WO2001048225A3 Production of heterologous proteins |
| 05/10/2002 | WO2001048190A3 Therapeutic uses of lna-modified oligonucleotides |
| 05/10/2002 | WO2001048182A3 Amino acid inducible expression system |
| 05/10/2002 | WO2001047963A3 Inhibitors of complement activation, their preparation and use |
| 05/10/2002 | WO2001047962A3 Attenuated microorganisms for the treatment of infection |
| 05/10/2002 | WO2001047955A3 Improvements in or relating to immune responses to hiv |
| 05/10/2002 | WO2001046455A3 Survivin promotion of angiogenesis |
| 05/10/2002 | WO2001046420A3 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
| 05/10/2002 | WO2001046391A3 Plant gene |
| 05/10/2002 | WO2001042781A3 Supracolonic aerodigestive neoplasm detection |
| 05/10/2002 | WO2001042481A3 Canine adenovirus vectors for the transfer of genes into target cells |
| 05/10/2002 | WO2001042472A3 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
| 05/10/2002 | WO2001042451A3 FULL-LENGTH HUMAN cDNAs ENCODING POTENTIALLY SECRETED PROTEINS |
| 05/10/2002 | WO2001042423A3 Compositions and methods for detecting stress-inducible proteins |
| 05/10/2002 | WO2001042296A3 Clasp-5 transmembrane protein |
| 05/10/2002 | WO2001042284A3 Protein comprising ig-like domain 4 of a vegf receptor mediates receptor dimerization, but not activation |
| 05/10/2002 | WO2001040478A3 Isolated polynucleotides having a reduced or an increased content of epigenetic control motifs and uses thereof |
| 05/10/2002 | WO2001040466A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/10/2002 | WO2001039599A3 Biological control by conditional dominant lethal genetic system |
| 05/10/2002 | WO2001038511A3 Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells |
| 05/10/2002 | WO2001036638A3 Polypeptides and nucleic acids encoding same |
| 05/10/2002 | WO2001036618A3 Transgenic mammals into which a period 1 promoter that confers rhythmical expression has been introduced |
| 05/10/2002 | WO2001036487A3 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/10/2002 | WO2001036486A3 Scfv antibodies against disease associated molecules |
| 05/10/2002 | WO2001036467A3 Mammalian receptor proteins; related reagents and methods |
| 05/10/2002 | WO2001036446A3 Use of g-protein coupled receptors (gpcrs) and modified gpcrs for the treatment of diseases |
| 05/10/2002 | WO2001036432A3 18 human secreted proteins |
| 05/10/2002 | WO2001034810A3 Genes essential for microbial proliferation |
| 05/10/2002 | WO2001033944A9 Compositions and methods for modulation of plant cell division |
| 05/10/2002 | WO2001033199A3 Universal fluorescent sensors |
| 05/10/2002 | WO2001032930A9 Methods and apparatuses for analyzing polynucleotide sequences |
| 05/10/2002 | WO2001032709A3 Polypeptides with non-natural primary signalling motifs |
| 05/10/2002 | WO2001031007A9 Nucleic acid molecules derived from rat brain and programmed cell death models |
| 05/10/2002 | WO2001030972A3 Regulation of gene expression by neuroleptic agents |
| 05/10/2002 | WO2001028580A3 Modulation of angiogenesis |
| 05/10/2002 | WO2001027326A3 Template-dependent ligation with pna-dna chimeric probes |
| 05/10/2002 | WO2001027146A9 Chemokine receptor |
| 05/10/2002 | WO2001026643A9 Inhibition of tumorigenic properties of melanoma cells |
| 05/10/2002 | WO2001025271A3 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
| 05/10/2002 | WO2001023533A3 Alzheimer's disease secretase, app substrates therefor, and uses therefor |
| 05/10/2002 | WO2001019859A3 LEPIDOPTERAN-ACTIVE BACILLUS THURINGIENSIS δ-ENDOTOXIN COMPOSITIONS AND METHODS OF USE |
| 05/10/2002 | WO2001014420A3 Novel members of the plexin family and uses thereof |
| 05/10/2002 | WO2001012827A9 Method for production of transgenic plants with increased tocopherol content |
| 05/10/2002 | WO2001007565A3 Monoterpene synthases from grand fir (abies grandis) |